Emerald Advisers’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q2
Sell
-7,709
Closed -$777K 349
2015
Q1
$777K Buy
7,709
+660
+9% +$67.1K 0.04% 263
2014
Q4
$737K Buy
7,049
+871
+14% +$91.8K 0.04% 259
2014
Q3
$659K Sell
6,178
-2,286
-27% -$237K 0.04% 264
2014
Q2
$886K Sell
8,464
-464
-5% -$46.9K 0.05% 260
2014
Q1
$877K Sell
8,928
-1,114
-11% -$103K 0.05% 258
2013
Q4
$920K Buy
10,042
+153
+2% +$14.1K 0.05% 248
2013
Q3
$857K Buy
9,889
+1,355
+16% +$122K 0.05% 248
2013
Q2
$733K Buy
+8,534
New +$724K 0.04% 253

Other funds holding JNJ

Emerald Advisers's JNJ Position: Q2 2015 in Review

Emerald Advisers sold out of Johnson & Johnson (JNJ) in Q2 2015, closing a stake of 7,709 shares — an estimated $777K sold.

Emerald Advisers first reported a position in JNJ in Q2 2013 and held it in 8 quarters. The position peaked at $920K in Q4 2013. 2,104 funds tracked by Wall St. Rank hold JNJ as of Q2 2015.

  • Emerald Advisers reported no remaining Johnson & Johnson position as of Q2 2015 after selling out during the quarter.
  • Emerald Advisers sold 7,709 Johnson & Johnson shares in Q2 2015, an estimated $777K.
  • Emerald Advisers first reported a position in Johnson & Johnson in Q2 2013 and held it in 8 quarters.
  • Emerald Advisers's Johnson & Johnson position peaked at $920K in Q4 2013.
  • 2,104 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2015.

Based on Emerald Advisers's 13F filing for Q2 2015, filed 28 Jul 2015.